Furthermore, targeting PIEZO1 or biophysical mechanisms that precede PIEZO1 activation (e.g., capillary-like constrictions) could prove a therapeutic avenue in combating metastatic disease. This evidence concerns the gene PIEZO1 and metastatic neoplasm.